Blog
Feeding the Microbiome: How MMTs Could Change the Landscape of Therapeutics
BlogTechnology Networks recently spoke with Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer at Kaleido Biosciences, to learn more about the development of Microbiome Metabolic Therapies (MMTs), and how Kaleido are advancing a pipeline of MMTs for a variety of disease indications.
Read More
Global Risk Reduction Approaches Put Pressure on PFAS Environmental Screening
BlogExposure to high levels of PFAS can be damaging to human health, and is associated with complications in reproduction, immune responses and some types of cancer. These issues, coupled with growing concerns about the impact of PFAS on the environment, mean that the detection and identification of PFAS has become a top priority for environmental testing laboratories worldwide.
Read More
Tackling Immune Dysregulation – A Key Driver of Disease
BlogImmune dysregulation plays a central role in many pathologies. We spoke with Dr Fabienne Charrier-Savournin, from Cisbio, to learn more about the mechanisms underpinning immune dysregulation and how this knowledge is applied for therapeutic intervention.
Read More
Detecting Sepsis Early
BlogWe recently spoke to Elena Sukhacheva, Director Medical and Scientific Affairs at Beckman Coulter, to learn about some of the challenges of diagnosing sepsis early, and how measuring Monocyte Distribution Width can be used as a sepsis biomarker to aid the process.
Read More
Mass Spectrometry in the Clinical Lab: The Importance of Choosing a Medical Device
BlogIn this interview, SCIEX’s Francis Fung highlights the benefits that mass spectrometry can bring to clinical laboratories, and discusses why when selecting a mass spectrometer, it is important to consider choosing a medical device.
Read More
Detecting Human and Cross-species Drug Toxicities With the Liver-Chip
BlogGeraldine A. Hamilton, PhD, President and Chief Scientific Officer of Emulate Inc., shares her perspectives on the challenges of using animal toxicity models and discusses how these can translate to late-stage attrition in drug development. She also highlights the advantages of using “organ-on-chip” technologies for toxicity testing and delves into the company’s recent findings related to the ability to reproduce human and cross-species drug toxicities using a liver-chip
Read More
Looking Back on Gene Editing Advances in 2019 and Towards What the Future May Hold
BlogWith constant conversations examining the potential of CRISPR technology, it can be hard to focus on what has been achieved since 2012 and to look toward the future to determine what may be achievable both in the near – and longer – term.
Read More
Exploring the Potential of Protein Degradation-focused Drug Discovery
BlogUbiquigent's Jason Brown and Jason Mundin discuss the role of the ubiquitin cascade in cellular signaling and explain how it can be exploited to support protein degradation-focused drug discovery.
Read More
Advances in Industrial Biocatalysis
BlogWe recently had the pleasure of speaking with Iwona Kaluzna, Sales and Marketing Director at InnoSyn to learn about the key challenges and most exciting research areas in biocatalysis.
Read More
Harnessing Gamma T Cells To Bring Effective Therapies to Patients
BlogTechnology Networks recently spoke with Natalie Mount, CEO of Adaptate BioTherapeutics, to learn more about the company's aims and the challenges faced when developing immunotherapies and advancing them into clinical studies.
Read More
